A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation.
about
SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial.Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects.Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus.Diabetes, cardiovascular disease and the microcirculation.Systematic review and meta-analysis of the effect of SGLT-2 inhibitors on microvascular outcomes in patients with type 2 diabetes: a review protocol.Focusing on Sodium Glucose Cotransporter-2 and the Sympathetic Nervous System: Potential Impact in Diabetic Retinopathy
P2860
A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
A randomised study of the impa ...... and macrovascular circulation.
@ast
A randomised study of the impa ...... and macrovascular circulation.
@en
type
label
A randomised study of the impa ...... and macrovascular circulation.
@ast
A randomised study of the impa ...... and macrovascular circulation.
@en
prefLabel
A randomised study of the impa ...... and macrovascular circulation.
@ast
A randomised study of the impa ...... and macrovascular circulation.
@en
P2093
P2860
P1476
A randomised study of the impa ...... and macrovascular circulation
@en
P2093
Agnes Jumar
Christian Ott
Kristina Striepe
Marina V Karg
Stefanie Friedrich
P2860
P2888
P356
10.1186/S12933-017-0510-1
P407
P577
2017-02-23T00:00:00Z
P6179
1083861533